Stay updated on Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide NIH announcement banner appears above the ClinicalTrials.gov navigation, linking to transition updates and explaining the agency’s change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T16:34:24.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T21:43:34.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T04:22:30.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden page, replacing the previous study record content. The header/footer and minimal navigation indicate that the study details are no longer accessible on this URL.
    Difference
    20%
    Check dated 2026-09-21T22:13:59.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, reflecting a new revision entry in the page history. This is a metadata change indicating an update to the page, not a modification of the study content.
    Difference
    0.0%
    Check dated 2026-08-31T16:35:41.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new line '2019 ( U.S. NIH Grant/Contract )' was added to the study identifiers section, indicating NIH funding for the trial. This contextual information updates the record but does not change the study design, eligibility, or outcomes as presented to users.
    Difference
    0.0%
    Check dated 2026-08-24T17:44:48.000Z thumbnail image

Stay in the know with updates to Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.